SUMMARY OF CHANGES IN FAIR VALUE OF LEVEL 3 WARRANT LIABILITIES MEASURED AT RECURRING BASIS (Details) - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Restructuring Cost and Reserve [Line Items] | ||
| Beginning balance, contingent consideration | $ 1,316,000 | |
| Change in fair value of contingent consideration | (1,316) | (2,498) |
| Ending balance, contingent consideration | 1,316,000 | |
| Beginning balance, warrant liability | 24,000 | 90,000 |
| Change in fair value of warrant liability | 8,000 | (66,000) |
| Ending balance, warrant liability | 32,000 | 24,000 |
| EB Acquisition [Member] | ||
| Restructuring Cost and Reserve [Line Items] | ||
| Contingent consideration assumed in EB acquisition | $ 3,814 | |
| X | ||||||||||
- Definition Change in fair value of contingent consideration. No definition available.
|
| X | ||||||||||
- Definition Contingent consideration assumed in acquisition. No definition available.
|
| X | ||||||||||
- Definition Amount of increase (decrease) of financial instrument classified in shareholders' equity measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. No definition available.
|
| X | ||||||||||
- Definition Fair value of financial instrument classified in shareholders' equity measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. No definition available.
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|